It belongs to a novel class of agents known as triple incretin receptor agonists, meaning it simultaneously activates three distinct hormone receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Understanding Recombinant Diabetes API Recombinant Diabetes API refers to active pharmaceutical ingredients that are produced through recombinant DNA technology
Delayed gastric emptying : GLP-1 slows the rate at which food leaves the stomach, leading to a more gradual absorption of glucose and contributing to postprandial glucose control
Quan L, Zhang Y, Crielaard BJ, Dusad A, Lele SM, Rijcken CJ, Metselaar JM, Kostkov H, Etrych T, Ulbrich K
Those who used Victoza alone experienced a decrease in BMD
Abnormal serum fatty acid profile in psoriatic arthritis